معرفی
Huned Patwa serves as Professor of Neurology at Yale School of Medicine, Chief of the Neurology Service at the VA Connecticut Healthcare System, Chief of the Division of Neuromuscular Medicine, and Co-Director of the Muscular Dystrophy Association Clinic. His academic career is deeply rooted in Yale where he completed his fellowship after earning his medical degree from New York University and residency at Yale-New Haven Hospital.
Dr. Patwa specializes in neuromuscular disorders with particular expertise in myasthenia gravis, peripheral neuropathy, and amyotrophic lateral sclerosis (ALS). His research has significantly contributed to understanding autoimmune neuromuscular conditions, with a focus on therapeutic interventions including eculizumab and intravenous immunoglobulin. He has been nationally recognized for his role in pivotal clinical trials that led to FDA approval of IVIG for chronic inflammatory demyelinating neuropathy.
Analysis of his recent publications reveals a strong emphasis on myasthenia gravis treatment outcomes, particularly regarding eculizumab's efficacy across diverse patient populations and muscle groups. His work often involves large international collaborations, reflecting the global significance of his research. Additional interests include end-of-life care in ALS and diagnostic techniques for neuromuscular disorders.
- Nationally recognized investigator in pivotal clinical trial leading to FDA approval of IVIG for chronic inflammatory demyelinating neuropathy
- Developed national guidelines for care of people with ALS
- Evaluator of quality of care delivered to veterans with ALS
Dr. Patwa has made substantial contributions to understanding neuromuscular disorders through clinical research and has been involved in developing treatment protocols that have directly impacted patient care standards. His work with the VA Connecticut Healthcare System demonstrates commitment to veteran healthcare, while his leadership roles at Yale position him at the forefront of academic neurology.
